Perrigo (PRGO) Amortizatization of Intangibles (2017 - 2026)
Perrigo (PRGO) posted quarterly Amortizatization of Intangibles of $2.2 million for Q1 2026, little changed year-over-year from $2.2 million in Q1 2025, and down 4.35% quarter-over-quarter from $2.3 million in Q4 2025.
Perrigo (PRGO) Amortizatization of Intangibles (2017 - 2026) Analysis & Trends
Perrigo (PRGO) has reported Amortizatization of Intangibles for 10 consecutive years, with $2.2 million the latest figure, recorded in Q1 2026.
- In Q1 2026, Amortizatization of Intangibles changed 0.0% year-over-year to $2.2 million; the TTM figure through Mar 2026 stood at $9.0 million (down 15.89% YoY), while the FY2025 annual figure was $9.0 million, up 1.12% from the prior year.
- Amortizatization of Intangibles eased to $2.2 million in Q1 2026 per PRGO's latest filing, from $2.3 million in the prior quarter.
- Across five years, Amortizatization of Intangibles topped out at $7.8 million in Q4 2024 and bottomed at -$4.1 million in Q3 2022.
- Historically, Amortizatization of Intangibles has averaged $1.3 million across 5 years, with a median of $700000.0 in 2023.
- Annual changes were most pronounced in 2022 — Amortizatization of Intangibles tumbled 485.71% — and 2024, when it surged 1460.0%.
- Perrigo's Amortizatization of Intangibles stood at $2.1 million in 2022, then tumbled by 76.19% to $500000.0 in 2023, then soared by 1460.0% to $7.8 million in 2024, then slumped by 70.51% to $2.3 million in 2025, then fell by 4.35% to $2.2 million in 2026.
- Business Quant data shows PRGO's Amortizatization of Intangibles at $2.2 million in Q1 2026, $2.3 million in Q4 2025, and $2.3 million in Q3 2025.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Amortizatization of Intangibles (Qtr) |
|---|---|---|---|---|---|
| 1 | Haleon | 43.91 Bn | 42.95 Bn | - | - |
| 2 | Teva Pharmaceutical Industries | 43.15 Bn | 39.49 Bn | 2.15 Bn | - |
| 3 | Zoetis | 31.52 Bn | 29.84 Bn | 1.05 Bn | - |
| 4 | Takeda Pharmaceutical | 28.58 Bn | 22.78 Bn | 5.10 Bn | - |
| 5 | United Therapeutics | 22.16 Bn | 19.50 Bn | 683.80 Mn | - |
| 6 | Viatris | 18.76 Bn | 17.87 Bn | 1.46 Bn | - |
| 7 | Neurocrine Biosciences | 15.48 Bn | 15.09 Bn | 935.80 Mn | 900,000.00 |
| 8 | Elanco Animal Health | 11.69 Bn | 11.16 Bn | 798.00 Mn | - |
| 9 | Dr Reddys Laboratories | 10.13 Bn | 9.96 Bn | - | - |
| 10 | Perrigo | 1.93 Bn | 1.53 Bn | 313.90 Mn | 1.90 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Jun 27, 2026 | 1.90 Mn |
| Jun 27, 2026 | 1.90 Mn |
| Mar 28, 2026 | 2.20 Mn |
| Mar 28, 2026 | 2.20 Mn |
| Dec 31, 2025 | 2.30 Mn |
| Dec 31, 2025 | 2.30 Mn |
| Sep 27, 2025 | 2.30 Mn |
| Sep 27, 2025 | 2.30 Mn |
| Jun 28, 2025 | 2.20 Mn |
| Jun 28, 2025 | 2.20 Mn |
| Mar 29, 2025 | 2.20 Mn |
| Mar 29, 2025 | 2.20 Mn |
| Dec 31, 2024 | 7.80 Mn |
| Dec 31, 2024 | 7.80 Mn |
| Sep 28, 2024 | 400,000.00 |
| Sep 28, 2024 | 400,000.00 |
| Jun 29, 2024 | 300,000.00 |
| Jun 29, 2024 | 300,000.00 |
| Mar 30, 2024 | 400,000.00 |
| Mar 30, 2024 | 400,000.00 |